Vol 12, No 3 (2010)
- Year: 2010
- Published: 15.09.2010
- Articles: 23
- URL: https://modernonco.orscience.ru/1815-1434/issue/view/1478
Articles
Na territorii Rossiyskoy FederatsiiGertseptin zaregistrirovan v kachestve terapiirasprostranennoy adenokartsinomy zheludkaili pishchevodno-zheludochnogo perekhodas opukholevoy giperekspressiey HER2
Journal of Modern Oncology. 2010;12(3):4-5



Obzor konferentsii ekspertovv oblasti lekarstvennoy terapii rakapochki «Novye vozmozhnosti v terapiimetastaticheskogo raka pochki»
Journal of Modern Oncology. 2010;12(3):6-7



Gastrointestinal'nye stromal'nyeopukholi: obzor materialov ASCO 2010
Journal of Modern Oncology. 2010;12(3):7-11



Dobavlenie Zomety (zoledronata)k ad\"yuvantnoy endokrinoterapiiuvelichivaet vyzhivaemost' bol'nykhrannim retseptor-pozitivnym rakommolochnoy zhelezy
Journal of Modern Oncology. 2010;12(3):12-15



Spornye aspekty HER2-diagnostiki
Journal of Modern Oncology. 2010;12(3):15-19



Bevatsizumab v lechenii HER2-negativnogometastaticheskogo raka molochnoy zhelezy:sovremennye dannye ob effektivnostii bezopasnosti
Journal of Modern Oncology. 2010;12(3):19-23



Kapetsitabin v ad\"yuvantnoy terapiiraka molochnoy zhelezy
Journal of Modern Oncology. 2010;12(3):23-27



Vozmozhnosti khimioterapii rakamolochnoy zhelezy, rezistentnogok antratsiklinam i taksanam
Journal of Modern Oncology. 2010;12(3):28-33



Rol' lapatiniba v terapiimetastaticheskogo raka molochnoyzhelezy s ekspressiey gormonal'nykhretseptorov
Journal of Modern Oncology. 2010;12(3):34-38



Izuchenie gemtsitabina (Gemzar®)i tsisplatina v pervoy linii terapiirasprostranennogo raka yaichnika(issledovanie II fazy)
Journal of Modern Oncology. 2010;12(3):40-45



Ingibitory tirozinkinazy retseptoraepidermal'nogo faktora rosta:pokhozhie, no raznye? (Referat)
Journal of Modern Oncology. 2010;12(3):46-52



Opyt primeneniya Avastina (bevatsizumaba)v sochetanii s khimioterapiey v lecheniirasprostranennykh form nemelkokletochnogoraka legkogo v otdelenii torakal'noyonkologii
Journal of Modern Oncology. 2010;12(3):53-57



Vozmozhnosti targetnoy terapiipri lechenii neyroendokrinnykhopukholey zheludochno-kishechnogotrakta i podzheludochnoy zhelezy
Journal of Modern Oncology. 2010;12(3):57-61



Primenenie preparata sorafenibpri lechenii gepatotsellyulyarnoy kartsinomy(Obzor klinicheskikh i neinterventsionnykhissledovaniy: issledovanie GIDEON)
Journal of Modern Oncology. 2010;12(3):62-64



Panitumumab v terapii metastaticheskogokolorektal'nogo raka: dannye klinicheskikhissledovaniy, problema kozhnoy toksichnosti
Journal of Modern Oncology. 2010;12(3):65-70



Trabektedin v lekarstvennom lecheniisarkom myagkikh tkaney
Journal of Modern Oncology. 2010;12(3):71-74



Mesto konservativnoy terapiiv lechenii raka slizistoy obolochki shcheki
Journal of Modern Oncology. 2010;12(3):76-79



Nekhodzhkinskie limfomy kishechnika -pervichnoe ekstranodal'noe porazhenie
Journal of Modern Oncology. 2010;12(3):80-84



Mekhanizmy mobilizatsii gemopoeticheskikhpredshestvennikov granulotsitarnymkoloniestimuliruyushchim faktorom
Journal of Modern Oncology. 2010;12(3):84-88



Anemiya i sposoby ee korrektsiiu onkologicheskikh bol'nykh
Journal of Modern Oncology. 2010;12(3):89-93



Bezopasnost' ibandronovoy kislotypri dlitel'nom primenenii
Journal of Modern Oncology. 2010;12(3):93-94



Astenicheskie rasstroystva,assotsiirovannye s khimioterapieyzlokachestvennykh novoobrazovaniy(Obzor literatury)
Journal of Modern Oncology. 2010;12(3):96-101



Tekhnicheskie vozmozhnosti primeneniyakleevoy substantsii pri khirurgicheskikhvmeshatel'stvakh na organakh bryushnoypolosti
Journal of Modern Oncology. 2010;12(3):102-112


